- Home
- PPSI vs RADX Comparison
PPSI vs RADX Comparison
Compare PPSI & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPSI
- RADX
- Stock Information
- Founded
- PPSI 2008
- RADX 2021
- Country
- PPSI United States
- RADX Australia
- Employees
- PPSI N/A
- RADX N/A
- Industry
- PPSI Electrical Products
- RADX
- Sector
- PPSI Industrials
- RADX
- Exchange
- PPSI Nasdaq
- RADX NYSE
- Market Cap
- PPSI 30.0M
- RADX 32.5M
- IPO Year
- PPSI N/A
- RADX N/A
- Fundamental
- Price
- PPSI $2.68
- RADX $4.05
- Analyst Decision
- PPSI Strong Buy
- RADX Strong Buy
- Analyst Count
- PPSI 1
- RADX 2
- Target Price
- PPSI $12.00
- RADX $13.50
- AVG Volume (30 Days)
- PPSI 37.0K
- RADX 22.6K
- Earning Date
- PPSI 05-15-2025
- RADX 02-26-2025
- Dividend Yield
- PPSI 55.87%
- RADX N/A
- EPS Growth
- PPSI N/A
- RADX N/A
- EPS
- PPSI 2.84
- RADX N/A
- Revenue
- PPSI $26,304,000.00
- RADX $204,609.00
- Revenue This Year
- PPSI $24.01
- RADX N/A
- Revenue Next Year
- PPSI $19.25
- RADX N/A
- P/E Ratio
- PPSI $0.94
- RADX N/A
- Revenue Growth
- PPSI 439.46
- RADX N/A
- 52 Week Low
- PPSI $2.25
- RADX $3.50
- 52 Week High
- PPSI $7.00
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- PPSI 47.79
- RADX N/A
- Support Level
- PPSI $2.64
- RADX N/A
- Resistance Level
- PPSI $2.76
- RADX N/A
- Average True Range (ATR)
- PPSI 0.10
- RADX 0.00
- MACD
- PPSI 0.00
- RADX 0.00
- Stochastic Oscillator
- PPSI 50.00
- RADX 0.00
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.